246 related articles for article (PubMed ID: 34338395)
1. Emetine exerts anticancer effects in U2OS human osteosarcoma cells via activation of p38 and inhibition of ERK, JNK, and β-catenin signaling pathways.
Son J; Lee SY
J Biochem Mol Toxicol; 2021 Oct; 35(10):e22868. PubMed ID: 34338395
[TBL] [Abstract][Full Text] [Related]
2. Emetine inhibits migration and invasion of human non-small-cell lung cancer cells via regulation of ERK and p38 signaling pathways.
Kim JH; Cho EB; Lee J; Jung O; Ryu BJ; Kim SH; Cho JY; Ryou C; Lee SY
Chem Biol Interact; 2015 Dec; 242():25-33. PubMed ID: 26332055
[TBL] [Abstract][Full Text] [Related]
3. Bufalin-inhibited migration and invasion in human osteosarcoma U-2 OS cells is carried out by suppression of the matrix metalloproteinase-2, ERK, and JNK signaling pathways.
Chueh FS; Chen YY; Huang AC; Ho HC; Liao CL; Yang JS; Kuo CL; Chung JG
Environ Toxicol; 2014 Jan; 29(1):21-9. PubMed ID: 21922632
[TBL] [Abstract][Full Text] [Related]
4. Dryofragin inhibits the migration and invasion of human osteosarcoma U2OS cells by suppressing MMP-2/9 and elevating TIMP-1/2 through PI3K/AKT and p38 MAPK signaling pathways.
Su Y; Wan D; Song W
Anticancer Drugs; 2016 Aug; 27(7):660-8. PubMed ID: 27243922
[TBL] [Abstract][Full Text] [Related]
5. Selaginella tamariscina (Beauv.) possesses antimetastatic effects on human osteosarcoma cells by decreasing MMP-2 and MMP-9 secretions via p38 and Akt signaling pathways.
Yang JS; Lin CW; Hsieh YS; Cheng HL; Lue KH; Yang SF; Lu KH
Food Chem Toxicol; 2013 Sep; 59():801-7. PubMed ID: 23811101
[TBL] [Abstract][Full Text] [Related]
6. Glabridin inhibits osteosarcoma migration and invasion via blocking the p38- and JNK-mediated CREB-AP1 complexes formation.
Jie Z; Xie Z; Zhao X; Sun X; Yu H; Pan X; Shen S; Qin A; Fang X; Fan S
J Cell Physiol; 2019 Apr; 234(4):4167-4178. PubMed ID: 30146723
[TBL] [Abstract][Full Text] [Related]
7. Kaempferol suppresses cell metastasis via inhibition of the ERK-p38-JNK and AP-1 signaling pathways in U-2 OS human osteosarcoma cells.
Chen HJ; Lin CM; Lee CY; Shih NC; Peng SF; Tsuzuki M; Amagaya S; Huang WW; Yang JS
Oncol Rep; 2013 Aug; 30(2):925-32. PubMed ID: 23708932
[TBL] [Abstract][Full Text] [Related]
8. Zoledronate blocks geranylgeranylation not farnesylation to suppress human osteosarcoma U2OS cells metastasis by EMT via Rho A activation and FAK-inhibited JNK and p38 pathways.
Cheng HL; Lin CW; Yang JS; Hsieh MJ; Yang SF; Lu KH
Oncotarget; 2016 Mar; 7(9):9742-58. PubMed ID: 26848867
[TBL] [Abstract][Full Text] [Related]
9. Tomatidine Represses Invasion and Migration of Human Osteosarcoma U2OS and HOS Cells by Suppression of Presenilin 1 and c-Raf-MEK-ERK Pathway.
Hsieh MH; Yang JS; Lin RC; Hsieh YH; Yang SF; Chang HR; Lu KH
Molecules; 2020 Jan; 25(2):. PubMed ID: 31941156
[TBL] [Abstract][Full Text] [Related]
10. Cinobufagin induces autophagy-mediated cell death in human osteosarcoma U2OS cells through the ROS/JNK/p38 signaling pathway.
Ma K; Zhang C; Huang MY; Li WY; Hu GQ
Oncol Rep; 2016 Jul; 36(1):90-8. PubMed ID: 27176794
[TBL] [Abstract][Full Text] [Related]
11. Geraniin inhibits migration and invasion of human osteosarcoma cancer cells through regulation of PI3K/Akt and ERK1/2 signaling pathways.
Wang Y; Wan D; Zhou R; Zhong W; Lu S; Chai Y
Anticancer Drugs; 2017 Oct; 28(9):959-966. PubMed ID: 28704237
[TBL] [Abstract][Full Text] [Related]
12. Shikonin inhibits prostate cancer cells metastasis by reducing matrix metalloproteinase-2/-9 expression via AKT/mTOR and ROS/ERK1/2 pathways.
Chen Y; Zheng L; Liu J; Zhou Z; Cao X; Lv X; Chen F
Int Immunopharmacol; 2014 Aug; 21(2):447-55. PubMed ID: 24905636
[TBL] [Abstract][Full Text] [Related]
13. Astrocyte elevated gene-1 (AEG-1) promotes osteosarcoma cell invasion through the JNK/c-Jun/MMP-2 pathway.
Wang F; Ke ZF; Wang R; Wang YF; Huang LL; Wang LT
Biochem Biophys Res Commun; 2014 Oct; 452(4):933-9. PubMed ID: 25204501
[TBL] [Abstract][Full Text] [Related]
14. Piperine inhibits proliferation of human osteosarcoma cells via G2/M phase arrest and metastasis by suppressing MMP-2/-9 expression.
Zhang J; Zhu X; Li H; Li B; Sun L; Xie T; Zhu T; Zhou H; Ye Z
Int Immunopharmacol; 2015 Jan; 24(1):50-8. PubMed ID: 25479727
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of oleandrin on the proliferation show and invasion of osteosarcoma cells in vitro by suppressing Wnt/β-catenin signaling pathway.
Ma Y; Zhu B; Liu X; Yu H; Yong L; Liu X; Shao J; Liu Z
J Exp Clin Cancer Res; 2015 Oct; 34():115. PubMed ID: 26444270
[TBL] [Abstract][Full Text] [Related]
16. The novel synthesized 6-fluoro-(3-fluorophenyl)-4-(3-methoxyanilino)quinazoline (LJJ-10) compound exhibits anti-metastatic effects in human osteosarcoma U-2 OS cells through targeting insulin-like growth factor-I receptor.
Chen KT; Hour MJ; Tsai SC; Chung JG; Kuo SC; Lu CC; Chiu YJ; Chuang YH; Yang JS
Int J Oncol; 2011 Sep; 39(3):611-9. PubMed ID: 21667022
[TBL] [Abstract][Full Text] [Related]
17. Nobiletin inhibits human osteosarcoma cells metastasis by blocking ERK and JNK-mediated MMPs expression.
Cheng HL; Hsieh MJ; Yang JS; Lin CW; Lue KH; Lu KH; Yang SF
Oncotarget; 2016 Jun; 7(23):35208-23. PubMed ID: 27144433
[TBL] [Abstract][Full Text] [Related]
18. Maclurin exerts anti-cancer effects in human osteosarcoma cells via prooxidative activity and modulations of PARP, p38, and ERK signaling.
Lee YJ; Lee SY
IUBMB Life; 2021 Aug; 73(8):1060-1072. PubMed ID: 34003554
[TBL] [Abstract][Full Text] [Related]
19. 3-Hydroxyflavone inhibits human osteosarcoma U2OS and 143B cells metastasis by affecting EMT and repressing u-PA/MMP-2 via FAK-Src to MEK/ERK and RhoA/MLC2 pathways and reduces 143B tumor growth in vivo.
Lu KH; Chen PN; Hsieh YH; Lin CY; Cheng FY; Chiu PC; Chu SC; Hsieh YS
Food Chem Toxicol; 2016 Nov; 97():177-186. PubMed ID: 27600294
[TBL] [Abstract][Full Text] [Related]
20. Fisetin activates Hippo pathway and JNK/ERK/AP-1 signaling to inhibit proliferation and induce apoptosis of human osteosarcoma cells via ZAK overexpression.
Fu CY; Chen MC; Tseng YS; Chen MC; Zhou Z; Yang JJ; Lin YM; Viswanadha VP; Wang G; Huang CY
Environ Toxicol; 2019 Aug; 34(8):902-911. PubMed ID: 31044527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
